

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.15701836 |
| 2 | response to peptidoglycan (GO:0032494) | 5.10145988 |
| 3 | cellular extravasation (GO:0045123) | 4.76041583 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.73851683 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.73851683 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.73851683 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.73851683 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.73851683 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.73851683 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.46754352 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.27444132 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 4.26110699 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.16926941 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.07956977 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07517260 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 3.84288441 |
| 17 | macrophage activation (GO:0042116) | 3.77444601 |
| 18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.69026037 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66053583 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 3.62633034 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56912474 |
| 22 | neutrophil mediated immunity (GO:0002446) | 3.54566829 |
| 23 | detection of other organism (GO:0098543) | 3.54121923 |
| 24 | germinal center formation (GO:0002467) | 3.43476410 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.42282578 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39587253 |
| 27 | regulation of leukocyte degranulation (GO:0043300) | 3.39164254 |
| 28 | response to host immune response (GO:0052572) | 3.37466104 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37466104 |
| 30 | histone H3-K36 demethylation (GO:0070544) | 3.37182386 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.36845035 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31701012 |
| 33 | microglial cell activation (GO:0001774) | 3.31355952 |
| 34 | detection of biotic stimulus (GO:0009595) | 3.30630503 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 3.30002348 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.26141626 |
| 37 | hepatocyte apoptotic process (GO:0097284) | 3.24688157 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23429572 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22677422 |
| 40 | response to host (GO:0075136) | 3.22677422 |
| 41 | response to host defenses (GO:0052200) | 3.22677422 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.22471772 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22471772 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20296150 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16547836 |
| 46 | respiratory burst (GO:0045730) | 3.13498003 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.11522583 |
| 48 | pinocytosis (GO:0006907) | 3.04890556 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.01913960 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.01266554 |
| 51 | regulation of mast cell activation (GO:0033003) | 2.96138898 |
| 52 | regulation of necroptotic process (GO:0060544) | 2.96049054 |
| 53 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95753911 |
| 54 | cellular response to ethanol (GO:0071361) | 2.94577259 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92723792 |
| 56 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.92664700 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91771913 |
| 58 | negative regulation of interleukin-17 production (GO:0032700) | 2.91291884 |
| 59 | positive thymic T cell selection (GO:0045059) | 2.90771174 |
| 60 | myeloid leukocyte mediated immunity (GO:0002444) | 2.90683300 |
| 61 | detection of bacterium (GO:0016045) | 2.89129252 |
| 62 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.86625496 |
| 63 | labyrinthine layer development (GO:0060711) | 2.85012823 |
| 64 | oligosaccharide catabolic process (GO:0009313) | 2.84809429 |
| 65 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84215095 |
| 66 | neutrophil activation (GO:0042119) | 2.82726516 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82519583 |
| 68 | positive regulation of leukocyte degranulation (GO:0043302) | 2.78702212 |
| 69 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74841033 |
| 70 | T-helper 1 type immune response (GO:0042088) | 2.74650025 |
| 71 | negative regulation of interleukin-8 production (GO:0032717) | 2.73969646 |
| 72 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72871570 |
| 73 | granulocyte activation (GO:0036230) | 2.72244970 |
| 74 | response to laminar fluid shear stress (GO:0034616) | 2.66180557 |
| 75 | regulation of B cell differentiation (GO:0045577) | 2.63246077 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 2.62812807 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62519168 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62499369 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62217012 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 2.62217012 |
| 81 | energy homeostasis (GO:0097009) | 2.62026300 |
| 82 | regulation of macrophage cytokine production (GO:0010935) | 2.61589724 |
| 83 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.59452889 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 2.59401116 |
| 85 | dosage compensation (GO:0007549) | 2.59101404 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.58338002 |
| 87 | mannose metabolic process (GO:0006013) | 2.57485792 |
| 88 | mature B cell differentiation involved in immune response (GO:0002313) | 2.57026537 |
| 89 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.55938613 |
| 90 | glycolipid catabolic process (GO:0019377) | 2.54997514 |
| 91 | neutrophil chemotaxis (GO:0030593) | 2.54521783 |
| 92 | mature B cell differentiation (GO:0002335) | 2.53063877 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.52861894 |
| 94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.51571737 |
| 95 | leukocyte aggregation (GO:0070486) | 2.49958631 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.48786425 |
| 97 | B cell homeostasis (GO:0001782) | 2.48270790 |
| 98 | neutrophil migration (GO:1990266) | 2.47124948 |
| 99 | negative regulation of necroptotic process (GO:0060546) | 2.46097456 |
| 100 | positive T cell selection (GO:0043368) | 2.45257630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.42389889 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.08225543 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.37224470 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31539989 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25969361 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17890621 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.11553499 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05855711 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.04980173 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04427871 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.96957688 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86911563 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75976859 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74516894 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.69116433 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68114684 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.67917492 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.65570120 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.61378519 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60754850 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.43458826 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.36309886 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.30415616 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25755434 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22964697 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15680027 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15176958 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.06484229 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04023619 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98984807 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97397727 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.93978543 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.91811155 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85739973 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82742159 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.82491930 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82087092 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.80254641 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79970342 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77031118 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75398564 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71619024 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66392918 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65422767 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64699070 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63793071 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59044385 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56735750 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53282889 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52150618 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46544151 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46277339 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43972452 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40573614 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34930035 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30643953 |
| 57 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29676075 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.25273076 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25119441 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24892415 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22571526 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21280431 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20426509 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19696859 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18378388 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18378388 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16569507 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16183893 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16110273 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15854650 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13365539 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12814406 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11644861 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10769413 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07955639 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06604951 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04693526 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02795219 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02775371 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99305173 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98960305 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98295995 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95113899 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95006772 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93800413 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93442071 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93330627 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91840040 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91281413 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89778336 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88948024 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88775017 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88330107 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88164905 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87049489 |
| 96 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87044437 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86354068 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81889688 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81512742 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81438848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.27763267 |
| 2 | MP0003303_peritoneal_inflammation | 3.26163249 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.23525805 |
| 4 | MP0003436_decreased_susceptibility_to | 2.77413514 |
| 5 | MP0003724_increased_susceptibility_to | 2.52483483 |
| 6 | MP0002419_abnormal_innate_immunity | 2.44643159 |
| 7 | MP0003828_pulmonary_edema | 2.40172304 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.16540531 |
| 9 | MP0000685_abnormal_immune_system | 2.13768299 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.10477576 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.07415534 |
| 12 | MP0001800_abnormal_humoral_immune | 2.05257076 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.05254315 |
| 14 | MP0008260_abnormal_autophagy | 2.02614746 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.00247335 |
| 16 | MP0005464_abnormal_platelet_physiology | 1.99497100 |
| 17 | MP0004947_skin_inflammation | 1.97285591 |
| 18 | MP0005025_abnormal_response_to | 1.94605209 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.93622090 |
| 20 | MP0009278_abnormal_bone_marrow | 1.85833717 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.85790517 |
| 22 | MP0002723_abnormal_immune_serum | 1.84803985 |
| 23 | MP0008057_abnormal_DNA_replication | 1.84712337 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.84663175 |
| 25 | MP0001819_abnormal_immune_cell | 1.84414991 |
| 26 | MP0009840_abnormal_foam_cell | 1.83130942 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.82491229 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.81983503 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.80954879 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.80587522 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.75595752 |
| 32 | MP0009785_altered_susceptibility_to | 1.73980868 |
| 33 | MP0005387_immune_system_phenotype | 1.66662936 |
| 34 | MP0001790_abnormal_immune_system | 1.66662936 |
| 35 | MP0002009_preneoplasia | 1.66271569 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.66115832 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.62420343 |
| 38 | MP0002405_respiratory_system_inflammati | 1.51638888 |
| 39 | MP0002398_abnormal_bone_marrow | 1.51369028 |
| 40 | MP0006082_CNS_inflammation | 1.50561913 |
| 41 | MP0001853_heart_inflammation | 1.49688455 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.48634853 |
| 43 | MP0000716_abnormal_immune_system | 1.48395080 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.46084652 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.43993460 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.43383606 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.43335856 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.41716963 |
| 49 | MP0003091_abnormal_cell_migration | 1.41619001 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.41558512 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.41180527 |
| 52 | MP0005671_abnormal_response_to | 1.40406710 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.40315152 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.40315152 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.38881094 |
| 56 | MP0002722_abnormal_immune_system | 1.37513083 |
| 57 | MP0004484_altered_response_of | 1.35401189 |
| 58 | MP0002132_abnormal_respiratory_system | 1.34873176 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 1.30734753 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.29900000 |
| 61 | MP0002006_tumorigenesis | 1.29100054 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.28799244 |
| 63 | MP0002429_abnormal_blood_cell | 1.22703335 |
| 64 | MP0009764_decreased_sensitivity_to | 1.20452057 |
| 65 | MP0004510_myositis | 1.13623065 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.10317506 |
| 67 | MP0000604_amyloidosis | 1.10008383 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.09882935 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.09737466 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.08140293 |
| 71 | MP0000858_altered_metastatic_potential | 1.07302680 |
| 72 | MP0004036_abnormal_muscle_relaxation | 1.06427930 |
| 73 | MP0003866_abnormal_defecation | 1.05251271 |
| 74 | MP0004233_abnormal_muscle_weight | 1.04912525 |
| 75 | MP0004381_abnormal_hair_follicle | 1.03241830 |
| 76 | MP0008469_abnormal_protein_level | 1.01228894 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.00094966 |
| 78 | MP0005166_decreased_susceptibility_to | 0.97763014 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.97098227 |
| 80 | MP0005310_abnormal_salivary_gland | 0.96885821 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.94703868 |
| 82 | MP0000343_altered_response_to | 0.94025270 |
| 83 | MP0004883_abnormal_blood_vessel | 0.91449493 |
| 84 | MP0008004_abnormal_stomach_pH | 0.89846030 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.87774837 |
| 86 | MP0000383_abnormal_hair_follicle | 0.87656761 |
| 87 | MP0003448_altered_tumor_morphology | 0.85823587 |
| 88 | MP0000749_muscle_degeneration | 0.84393937 |
| 89 | MP0004130_abnormal_muscle_cell | 0.84376802 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.82821896 |
| 91 | MP0005083_abnormal_biliary_tract | 0.82576112 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.82453305 |
| 93 | MP0003075_altered_response_to | 0.82040707 |
| 94 | MP0001851_eye_inflammation | 0.81841820 |
| 95 | MP0009115_abnormal_fat_cell | 0.80287740 |
| 96 | MP0005164_abnormal_response_to | 0.79827916 |
| 97 | MP0000490_abnormal_crypts_of | 0.79093425 |
| 98 | MP0001849_ear_inflammation | 0.77939635 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.77003699 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.74111522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.74784313 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.62632980 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.40230177 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.89562943 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.61838521 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.61838521 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.61838521 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.48686297 |
| 9 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.46911851 |
| 10 | Colitis (HP:0002583) | 3.41595743 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.22155816 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11248074 |
| 13 | Cellulitis (HP:0100658) | 3.05750450 |
| 14 | Recurrent viral infections (HP:0004429) | 3.05726586 |
| 15 | Myositis (HP:0100614) | 3.05291725 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99953342 |
| 17 | Gingivitis (HP:0000230) | 2.96934476 |
| 18 | Orchitis (HP:0100796) | 2.88182271 |
| 19 | Recurrent skin infections (HP:0001581) | 2.85223491 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 2.82596417 |
| 21 | Optic neuritis (HP:0100653) | 2.82596417 |
| 22 | Inflammation of the large intestine (HP:0002037) | 2.81990300 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.81605516 |
| 24 | Myocardial infarction (HP:0001658) | 2.78344354 |
| 25 | T lymphocytopenia (HP:0005403) | 2.78142958 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.69314507 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.68928086 |
| 28 | Amyloidosis (HP:0011034) | 2.67956884 |
| 29 | Subacute progressive viral hepatitis (HP:0006572) | 2.66085322 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 2.61815167 |
| 31 | Stomatitis (HP:0010280) | 2.56661119 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54829184 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54829184 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.53159780 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.53031085 |
| 36 | Meningitis (HP:0001287) | 2.51404483 |
| 37 | Granulocytopenia (HP:0001913) | 2.50211844 |
| 38 | Arterial thrombosis (HP:0004420) | 2.48816348 |
| 39 | Viral hepatitis (HP:0006562) | 2.48733670 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.47959840 |
| 41 | Loss of speech (HP:0002371) | 2.45440249 |
| 42 | Chest pain (HP:0100749) | 2.39884672 |
| 43 | Obstructive lung disease (HP:0006536) | 2.39877680 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39877680 |
| 45 | Spinal cord lesions (HP:0100561) | 2.37816087 |
| 46 | Syringomyelia (HP:0003396) | 2.37816087 |
| 47 | Dysmetric saccades (HP:0000641) | 2.34226462 |
| 48 | Leukocytosis (HP:0001974) | 2.33910395 |
| 49 | Vasculitis (HP:0002633) | 2.30939713 |
| 50 | Eosinophilia (HP:0001880) | 2.30261510 |
| 51 | Gingival bleeding (HP:0000225) | 2.27595104 |
| 52 | Increased connective tissue (HP:0009025) | 2.26628094 |
| 53 | Osteomyelitis (HP:0002754) | 2.26123462 |
| 54 | Fatigue (HP:0012378) | 2.24153015 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.19381253 |
| 56 | Thrombocytosis (HP:0001894) | 2.14585474 |
| 57 | Polycythemia (HP:0001901) | 2.14278058 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.14218807 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.14213858 |
| 60 | Urticaria (HP:0001025) | 2.12523438 |
| 61 | Abnormality of the columella (HP:0009929) | 2.09818573 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08793404 |
| 63 | Hyporeflexia of lower limbs (HP:0002600) | 2.08025919 |
| 64 | Abnormality of the endocardium (HP:0004306) | 2.07830166 |
| 65 | Epistaxis (HP:0000421) | 2.07725727 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.07086494 |
| 67 | Difficulty running (HP:0009046) | 2.02407906 |
| 68 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.99662791 |
| 69 | Slow saccadic eye movements (HP:0000514) | 1.98633995 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 1.97463323 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 1.97330962 |
| 72 | Thoracic kyphosis (HP:0002942) | 1.97140135 |
| 73 | Dysostosis multiplex (HP:0000943) | 1.96539747 |
| 74 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93402484 |
| 75 | Bulbar palsy (HP:0001283) | 1.91245990 |
| 76 | Hemoptysis (HP:0002105) | 1.90915034 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90199491 |
| 78 | Periodontitis (HP:0000704) | 1.88357302 |
| 79 | Pustule (HP:0200039) | 1.88249110 |
| 80 | Micronodular cirrhosis (HP:0001413) | 1.87718102 |
| 81 | Hematochezia (HP:0002573) | 1.85377517 |
| 82 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.83247222 |
| 83 | Amaurosis fugax (HP:0100576) | 1.83170493 |
| 84 | Increased IgE level (HP:0003212) | 1.81081886 |
| 85 | Exercise-induced myalgia (HP:0003738) | 1.79460634 |
| 86 | Malnutrition (HP:0004395) | 1.79006667 |
| 87 | Encephalitis (HP:0002383) | 1.77169435 |
| 88 | Keratoconjunctivitis (HP:0001096) | 1.77040053 |
| 89 | Abnormality of T cells (HP:0002843) | 1.77029668 |
| 90 | Prolonged bleeding time (HP:0003010) | 1.76399146 |
| 91 | Acute myeloid leukemia (HP:0004808) | 1.76017559 |
| 92 | Thick nail (HP:0001805) | 1.75960429 |
| 93 | Abnormality of the thoracic spine (HP:0100711) | 1.75065699 |
| 94 | IgM deficiency (HP:0002850) | 1.74942085 |
| 95 | Polyneuropathy (HP:0001271) | 1.74538726 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 1.74457885 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74457885 |
| 98 | Resting tremor (HP:0002322) | 1.73705510 |
| 99 | Thoracolumbar scoliosis (HP:0002944) | 1.72762266 |
| 100 | EMG: myopathic abnormalities (HP:0003458) | 1.72650650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.03167278 |
| 2 | MAP2K3 | 2.98734468 |
| 3 | PRPF4B | 2.90833658 |
| 4 | MAP3K14 | 2.82063855 |
| 5 | IRAK3 | 2.73141645 |
| 6 | CDK12 | 2.34336810 |
| 7 | RIPK4 | 2.34187203 |
| 8 | BMPR2 | 1.92624606 |
| 9 | MAP4K1 | 1.89391464 |
| 10 | TAOK3 | 1.87666751 |
| 11 | ZAP70 | 1.87301201 |
| 12 | IKBKE | 1.86947769 |
| 13 | IRAK4 | 1.86518492 |
| 14 | MAP3K13 | 1.82550498 |
| 15 | TTN | 1.81908071 |
| 16 | TYK2 | 1.70663959 |
| 17 | TBK1 | 1.69648054 |
| 18 | CSK | 1.69082016 |
| 19 | BTK | 1.68006467 |
| 20 | SCYL2 | 1.66963826 |
| 21 | MAP3K6 | 1.64723424 |
| 22 | TRIB3 | 1.64167422 |
| 23 | MAP3K1 | 1.64091625 |
| 24 | IRAK2 | 1.57002257 |
| 25 | PIK3CG | 1.54530298 |
| 26 | GRK6 | 1.50651707 |
| 27 | MARK3 | 1.50227569 |
| 28 | OBSCN | 1.46543598 |
| 29 | EEF2K | 1.42979120 |
| 30 | PBK | 1.41617300 |
| 31 | FGR | 1.35301307 |
| 32 | FES | 1.30768161 |
| 33 | JAK3 | 1.30284027 |
| 34 | JAK1 | 1.29670509 |
| 35 | CDK6 | 1.21240217 |
| 36 | IKBKB | 1.20375220 |
| 37 | SYK | 1.20269275 |
| 38 | KSR2 | 1.13226260 |
| 39 | HCK | 1.12137967 |
| 40 | RET | 1.10807922 |
| 41 | ICK | 1.09642590 |
| 42 | ERN1 | 1.07376759 |
| 43 | SGK3 | 1.02566384 |
| 44 | TGFBR2 | 1.02337929 |
| 45 | RPS6KB2 | 1.01136997 |
| 46 | MAP3K10 | 1.00180270 |
| 47 | IRAK1 | 0.99988853 |
| 48 | TRPM7 | 0.99268627 |
| 49 | PKN2 | 0.98748602 |
| 50 | STK10 | 0.98175381 |
| 51 | MAP3K2 | 0.97583570 |
| 52 | MAP3K3 | 0.95483183 |
| 53 | MAP3K5 | 0.91910413 |
| 54 | STK4 | 0.90233935 |
| 55 | JAK2 | 0.88171382 |
| 56 | NEK9 | 0.87420922 |
| 57 | MARK2 | 0.86628954 |
| 58 | FGFR3 | 0.84748670 |
| 59 | LYN | 0.82823690 |
| 60 | CSF1R | 0.81986776 |
| 61 | MOS | 0.81816534 |
| 62 | MAPK7 | 0.80903877 |
| 63 | PDPK1 | 0.80726205 |
| 64 | SGK2 | 0.79712537 |
| 65 | TEC | 0.79166887 |
| 66 | KIT | 0.77204291 |
| 67 | LCK | 0.77100919 |
| 68 | PIM1 | 0.75393691 |
| 69 | PINK1 | 0.74163442 |
| 70 | CAMK1D | 0.73930692 |
| 71 | PDK1 | 0.73821327 |
| 72 | NEK6 | 0.72205052 |
| 73 | TXK | 0.71913710 |
| 74 | MATK | 0.70105207 |
| 75 | STK24 | 0.69350977 |
| 76 | CHUK | 0.68284716 |
| 77 | MTOR | 0.66449383 |
| 78 | MELK | 0.66406507 |
| 79 | MAP2K4 | 0.65093038 |
| 80 | BRD4 | 0.63624909 |
| 81 | RAF1 | 0.62612312 |
| 82 | CDK4 | 0.62115506 |
| 83 | MAPK12 | 0.61184225 |
| 84 | NME2 | 0.60959114 |
| 85 | PDK2 | 0.60353113 |
| 86 | ITK | 0.59170562 |
| 87 | SMG1 | 0.58999225 |
| 88 | RPS6KB1 | 0.58916742 |
| 89 | AKT3 | 0.54338747 |
| 90 | MAPK11 | 0.50636982 |
| 91 | LRRK2 | 0.50615635 |
| 92 | RPS6KC1 | 0.49128144 |
| 93 | RPS6KL1 | 0.49128144 |
| 94 | WNK1 | 0.47822092 |
| 95 | GRK7 | 0.47395711 |
| 96 | TAOK2 | 0.46100399 |
| 97 | CAMK1G | 0.42040731 |
| 98 | CDC42BPA | 0.39507612 |
| 99 | MAP3K8 | 0.36255361 |
| 100 | PRKCQ | 0.36123045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.55228098 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55035210 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45331627 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.42324021 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13513842 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94493607 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88166953 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 1.87648154 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85075548 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.81912074 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73220949 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72741008 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66409744 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.65900066 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65467028 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62760614 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58490993 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55551097 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55203740 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54820371 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54731462 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.54434159 |
| 23 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.46999561 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.46893511 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.39275975 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.38161933 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36441211 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36174187 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35750879 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35433868 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27982691 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.25297795 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25223119 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20997320 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.20815483 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.20496177 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.19585223 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.19323206 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16573049 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15872010 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14609328 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13834719 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13697895 |
| 44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11901262 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11737087 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05202234 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05010852 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.01618461 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99619320 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98968175 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97802803 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96351613 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94876887 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.94171158 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93886178 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.93779300 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.91904286 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.90207584 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89219636 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.88035289 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88000372 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.86691372 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85440308 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.84036797 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83384868 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83379428 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83347529 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82554200 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.81706187 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81600994 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81103186 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80507760 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80322454 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77745447 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77063922 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76984294 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.75375536 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75321652 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72715588 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71647037 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.70799020 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70223685 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69866957 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68359319 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68302613 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65864300 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65556820 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62779435 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62699758 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62165433 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59055614 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58694540 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.58319671 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55013030 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54790661 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54209874 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51931589 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51105444 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48254247 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48026757 |

